Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Proc Natl Acad Sci U S A ; 107(46): 19927-32, 2010 Nov 16.
Artículo en Inglés | MEDLINE | ID: mdl-21041635

RESUMEN

Calcium signaling is essential for the differentiation of many cell types, including skeletal muscle cells, but its mechanisms remain elusive. Here we demonstrate a crucial role for nicotinic acid adenine dinucleotide phosphate (NAADP) signaling in skeletal muscle differentiation. Although the inositol trisphosphate pathway may have a partial role to play in this process, the ryanodine signaling cascade is not involved. In both skeletal muscle precursors and C2C12, cells interfering with NAADP signaling prevented differentiation, whereas promoting NAADP signaling potentiated differentiation. Moreover, siRNA knockdown of two-pore channels, the target of NAADP, attenuated differentiation. The data presented here strongly suggest that in myoblasts, NAADP acts at acidic organelles on the recently discovered two-pore channels to promote differentiation.


Asunto(s)
Canales de Calcio/metabolismo , Diferenciación Celular , Músculo Esquelético/citología , NADP/análogos & derivados , Ácidos/metabolismo , Animales , Calcio/metabolismo , Canales de Calcio/genética , Células Cultivadas , Regulación hacia Abajo/genética , Retículo Endoplásmico/metabolismo , Inositol 1,4,5-Trifosfato/metabolismo , Ratones , NADP/metabolismo , Rianodina/metabolismo , Sistemas de Mensajero Secundario , Transducción de Señal
2.
Differentiation ; 83(5): 271-81, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22469857

RESUMEN

Rhabdomyosarcoma is a soft tissue sarcoma mainly seen in children. Despite considerable progress within the last few years, therapeutic approaches for this type of tumor are still limited. The respective tumor cells originate from myogenic precursor cells and are characterized by a blockade in their differentiation program. Interestingly, there is a direct inverse correlation between the differentiation status of a specific rhabdomyosarcoma cell and its metastatic potential. Thus, here, we tested whether the ubiquitous transcription factor NF-κB, which regulates myogenic differentiation and is also a promising therapeutic target in the treatment of other types of tumors, might be an interesting candidate for the development of novel rhabdomyosarcoma treatment strategies. For this purpose, we analyzed NF-κB activity (classical pathway) in myoblasts with different differentiation potential, specifically in three different rhabdomyosarcoma cell lines. In addition, we inhibited NF-κB activity in these cells and analyzed the effects on myogenic differentiation. We show that after the induction of differentiation, NF-κB activity declines rapidly in normal myoblasts, but only slightly in rhabdomyosarcoma cells. However, after treatment of the cells with two different small-molecule NF-κB-inhibiting compounds, the IKK inhibitor curcumin and the proteasome inhibitor lactacystin, we found that neither curcumin nor lactacystin promoted myogenic differentiation in either normal myoblasts or rhabdomyosarcoma cells. Taken together, our data suggest that treatment with curcumin or lactacystin might not be a suitable approach in the treatment of rhabdomyosarcoma.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Desarrollo de Músculos , FN-kappa B/metabolismo , Rabdomiosarcoma/metabolismo , Acetilcisteína/análogos & derivados , Acetilcisteína/farmacología , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Curcumina/farmacología , Humanos , Terapia Molecular Dirigida , Mioblastos/citología , Mioblastos/metabolismo , FN-kappa B/antagonistas & inhibidores , Fosforilación/efectos de los fármacos , Rabdomiosarcoma/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos
3.
Differentiation ; 81(2): 99-106, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21131124

RESUMEN

We could recently demonstrate an important role of receptor interacting protein-2 (RIP2), an activator of nuclear factor kappa B (NF-κB) and a target of activated receptors of the tumor necrosis factor receptor (TNFR) type, in myogenic differentiation and regeneration. Here, we analyze a potential role of TNFR associated factor 6 (TRAF6), which also associates with the cytoplasmic domain of TNFR type, but also IL-1-R and TLR type receptors, and activates NF-κB, in these processes. Specifically, we show that during myogenic differentiation in vitro, traf6 gene expression is downregulated in normal myoblasts, but not in rhabdomyosarcoma cells, suggesting a role of the TRAF6 protein in this process. Inhibition of traf6 expression using specific siRNAs led to an inhibition of both myoblast proliferation and differentiation, whereas inhibition of the TRAF6 effector NF-κB alone in our system only blocked proliferation. Finally, we demonstrate that the traf6 gene is downregulated in skeletal muscle tissue of the dystrophic mdx mouse. Taken together, these data argue for a role of TRAF6 in the regulation of skeletal muscle differentiation and regeneration.


Asunto(s)
Diferenciación Celular/genética , Desarrollo de Músculos/genética , Mioblastos Esqueléticos/citología , Factor 6 Asociado a Receptor de TNF/metabolismo , Animales , Técnicas de Cultivo de Célula , Proliferación Celular , Humanos , Ratones , Neoplasias de los Músculos/genética , Mioblastos Esqueléticos/fisiología , FN-kappa B/genética , ARN Interferente Pequeño/genética , Proteína Serina-Treonina Quinasa 2 de Interacción con Receptor , Proteína Serina-Treonina Quinasas de Interacción con Receptores/genética , Proteína Serina-Treonina Quinasas de Interacción con Receptores/metabolismo , Receptores de Interleucina-1/metabolismo , Receptores del Factor de Necrosis Tumoral/genética , Regeneración/genética , Rabdomiosarcoma/genética , Transducción de Señal/genética , Factor 6 Asociado a Receptor de TNF/genética
4.
Trends Biochem Sci ; 29(3): 111-8, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15003268

RESUMEN

Since the beginning of the last century, seminal discoveries have identified pyridine nucleotides as the major redox carriers in all organisms. Recent research has unravelled an unexpectedly wide array of signalling pathways that involve nicotinamide adenine dinucleotide (NAD) and its phosphorylated form, NADP. NAD serves as substrate for protein modification including protein deacetylation, and mono- and poly-ADP-ribosylation. Both NAD and NADP represent precursors of intracellular calcium-mobilizing molecules. It is now beyond doubt that NAD(P)-mediated signal transduction does not merely regulate metabolic pathways, but might hold a key position in the control of fundamental cellular processes. The comprehensive molecular characterization of NAD biosynthetic pathways over the past few years has further extended the understanding of the multiple roles of pyridine nucleotides in cell biology.


Asunto(s)
Esperanza de Vida , NADP/metabolismo , NAD/metabolismo , Transducción de Señal/fisiología , Adenosina Difosfato Ribosa/metabolismo , Animales , Calcio/metabolismo , Células Eucariotas , Humanos , Modelos Biológicos , Estructura Molecular , NAD/biosíntesis , NADP/análogos & derivados , NADP/biosíntesis
5.
Eur J Cell Biol ; 87(1): 31-8, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17889962

RESUMEN

TIS11B is a zinc-finger protein of the tristetraprolin (TTP) family. Using cDNA microarray analysis, we could identify the Tis11B gene based on its differential expression in myogenesis. Here, we demonstrate that expression of the Tis11B gene is strongly induced during differentiation of the murine myoblast cell line C2C12. By contrast, expression of Ttp itself was not induced in myogenesis. Pretreatment of the cells with the translation inhibitor cycloheximide demonstrated that Tis11B was a primary response gene in this process. In addition, pretreatment with the transcription inhibitor actinomycin D demonstrated that gene expression was regulated at the transcriptional level. Since specific inhibitors of p38 MAP kinase completely blocked Tis11B induction, we conclude that expression of the Tis11B gene is regulated at least in part by this signaling pathway which plays a central role in myogenesis. Induction of Tis11B expression was also observed in primary myoblasts isolated from two different mouse strains, indicating physiological relevance of our results. In addition, TIS11B might also be an important player during myogenic differentiation and regeneration in vivo, as we detected a marked decrease in expression in several muscle tissues of the dystrophic mdx mouse, a model for continuous muscle degeneration and regeneration. These data suggest that TIS11B is an important regulator of myogenesis.


Asunto(s)
Diferenciación Celular/fisiología , Regulación de la Expresión Génica/fisiología , Desarrollo de Músculos/fisiología , Mioblastos/metabolismo , Proteínas Nucleares/biosíntesis , Proteínas de Unión al ARN/biosíntesis , Regeneración/fisiología , Animales , Factor 1 de Respuesta al Butirato , Diferenciación Celular/efectos de los fármacos , Línea Celular , Cicloheximida/farmacología , Dactinomicina/farmacología , Modelos Animales de Enfermedad , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/efectos de los fármacos , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Endogámicos mdx , Desarrollo de Músculos/efectos de los fármacos , Distrofias Musculares/genética , Distrofias Musculares/metabolismo , Distrofia Muscular Animal/genética , Distrofia Muscular Animal/metabolismo , Mioblastos/citología , Proteínas Nucleares/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de la Síntesis de la Proteína/farmacología , Proteínas de Unión al ARN/genética , Regeneración/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Transcripción Genética/efectos de los fármacos , Transcripción Genética/fisiología , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
6.
Eur J Cell Biol ; 91(2): 150-5, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22154550

RESUMEN

NAC (nascent polypeptide associated complex) is a heterodimer consisting of an α and a ß subunit. skNAC (skeletal and heart muscle-specific form of αNAC) is a variant of αNAC, which is induced in muscle differentiation and regeneration. We show here that skNAC expression is regulated by p38 MAPK, which plays a crucial role in myogenesis. Furthermore, inhibition of skNAC expression in myoblasts via specific siRNAs might lead to disturbed incorporation of myosin heavy chain (MyHC) into sarcomeres, however, it has no inhibitory effect on absolute MyHC protein levels. Taken together, our data suggest that skNAC regulates specific aspects of myogenesis.


Asunto(s)
Chaperonas Moleculares/metabolismo , Músculo Esquelético/metabolismo , Mioblastos/metabolismo , Animales , Diferenciación Celular , Células Cultivadas , Cicloheximida/farmacología , Dactinomicina/farmacología , Ratones , Chaperonas Moleculares/antagonistas & inhibidores , Chaperonas Moleculares/genética , Desarrollo de Músculos , Músculo Esquelético/citología , Músculo Esquelético/efectos de los fármacos , Mioblastos/citología , Mioblastos/efectos de los fármacos , Cadenas Pesadas de Miosina/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , ARN Interferente Pequeño/genética , Regeneración , Sarcómeros/metabolismo , Transducción de Señal , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
7.
Proc Natl Acad Sci U S A ; 104(10): 3765-70, 2007 Mar 06.
Artículo en Inglés | MEDLINE | ID: mdl-17360427

RESUMEN

Nuclear NAD(+) metabolism constitutes a major component of signaling pathways. It includes NAD(+)-dependent protein deacetylation by members of the Sir2 family and protein modification by poly(ADP-ribose) polymerase 1 (PARP-1). PARP-1 has emerged as an important mediator of processes involving DNA rearrangements. High-affinity binding to breaks in DNA activates PARP-1, which attaches poly(ADP-ribose) (PAR) to target proteins. NMN adenylyl transferases (NMNATs) catalyze the final step of NAD(+) biosynthesis. We report here that the nuclear isoform NMNAT-1 stimulates PARP-1 activity and binds to PAR. Its overexpression in HeLa cells promotes the relocation of apoptosis-inducing factor from the mitochondria to the nucleus, a process known to depend on poly(ADP-ribosyl)ation. Moreover, NMNAT-1 is subject to phosphorylation by protein kinase C, resulting in reduced binding to PAR. Mimicking phosphorylation, substitution of the target serine residue by aspartate precludes PAR binding and stimulation of PARP-1. We conclude that, depending on its state of phosphorylation, NMNAT-1 binds to activated, automodifying PARP-1 and thereby amplifies poly(ADP-ribosyl)ation.


Asunto(s)
Regulación Neoplásica de la Expresión Génica , Nicotinamida-Nucleótido Adenililtransferasa/química , Poli(ADP-Ribosa) Polimerasas/biosíntesis , Poli(ADP-Ribosa) Polimerasas/genética , Apoptosis , Factor Inductor de la Apoptosis/metabolismo , Núcleo Celular/metabolismo , ADN/química , Fibroblastos/metabolismo , Células HeLa , Humanos , Fosforilación , Isoformas de Proteínas , Proteína Quinasa C/metabolismo , Transporte de Proteínas , Serina/química
8.
J Biol Chem ; 280(43): 36334-41, 2005 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-16118205

RESUMEN

Nicotinamide mononucleotide adenylyltransferase (NMNAT) is the central enzyme of the NAD biosynthetic pathway. Three human NMNAT isoforms have recently been identified, but isoform-specific functions are presently unknown, although a tissue-specific role has been suggested. Analyses of the subcellular localization confirmed NMNAT1 to be a nuclear protein, whereas NMNAT2 and -3 were localized to the Golgi complex and the mitochondria, respectively. This differential subcellular localization points to an organelle-specific, nonredundant function of each of the three proteins. Comparison of the kinetic properties showed that particularly NMNAT3 exhibits a high tolerance toward substrate modifications. Moreover, as opposed to preferred NAD+ synthesis by NMNAT1, the other two isoforms could also form NADH directly from the reduced nicotinamide mononucleotide, supporting a hitherto unknown pathway of NAD generation. A variety of physiological intermediates was tested and exerted only minor influence on the catalytic activities of the NMNATs. However, gallotannin was found to be a potent inhibitor, thereby compromising its use as a specific inhibitor of poly-ADP-ribose glycohydrolase. The presence of substrate-specific and independent nuclear, mitochondrial, and Golgi-specific NAD biosynthetic pathways is opposed to the assumption of a general cellular NAD pool. Their existence appears to be consistent with important compartment-specific functions rather than to reflect simple functional redundance.


Asunto(s)
Aparato de Golgi/metabolismo , Nicotinamida-Nucleótido Adenililtransferasa/química , Adenosina Trifosfato/química , Catálisis , Dominio Catalítico , Línea Celular , Núcleo Celular/metabolismo , Clonación Molecular , ADN Complementario/metabolismo , Glicósido Hidrolasas/química , Células HeLa , Humanos , Taninos Hidrolizables/química , Cinética , Nicotinamida-Nucleótido Adenililtransferasa/fisiología , Poli(ADP-Ribosa) Polimerasas/química , Conformación Proteica , Isoformas de Proteínas , Especificidad por Sustrato , Factores de Tiempo , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA